Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai
Patent
1984-09-11
1988-07-19
Bell, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ether doai
514877, 604 48, A61K 3108
Patent
active
047585960
ABSTRACT:
Method for dissolving cholesterol calculus in vitro or in vivo comprising contacting the cholesterol calculus with methyl tertiary-butyl ether.
REFERENCES:
patent: 1846596 (1932-02-01), Hertzberg
patent: 2024967 (1935-12-01), Dierker
patent: 3042041 (1962-07-01), Jascalevich
patent: 3142299 (1964-07-01), Henderson
patent: 3316910 (1967-05-01), Davis
patent: 3329147 (1967-07-01), Barron
patent: 3426743 (1969-02-01), Chestnut et al.
patent: 3429313 (1969-02-01), Romanelli
patent: 3885567 (1975-05-01), Ross
patent: 3888994 (1986-06-01), Wagner et al.
patent: 3892226 (1975-07-01), Rosen
patent: 3955574 (1976-05-01), Rubinstein
patent: 4041947 (1977-08-01), Weiss et al.
patent: 4205086 (1980-05-01), Babayan
patent: 4205176 (1980-05-01), Zestermann et al.
patent: 4255096 (1981-03-01), Coker et al.
patent: 4282873 (1981-08-01), Roth
patent: 4315506 (1982-02-01), Kayser et al.
patent: 4447226 (1984-05-01), Mayoral
patent: 4457755 (1984-07-01), Wilson
patent: 4464399 (1984-08-01), Hofmann
patent: 4516398 (1986-05-01), Wuchinich
patent: 4525156 (1985-06-01), Benusa et al.
patent: 4526575 (1985-07-01), Roblejo
Buglios; T. F. et al., "Methyl Tertiary-Butyl Ether (MTBE) in Expired Air and Methanol in Blood Do Not Reach Potentially Harmful Levels After Gallbladder and Duodenal Instillation of Therapeutic Doses of MTBE in Dogs", Gastroenterology-vol. 86(5), Part 2, May 1984, p. 1313.
Buglios; T. F. et al.-"Rapid Gallstone Dissolution in Dogs Using Methyl Tertiary-Butyl Ether and an Aspiration-Infusion Pump", Gastroenterology-vol. 86 (5), Part 2, May 1984, p. 1350.
The Merck Index, 10th Ed. (1983), pub. by Merck & Co., Rahway, N.J., pp. 865-866, Item 5908, Methyl Tertiary Butyl Ether.
Allen, M. J. et al., "Rapid Dissolution of Gallstones by Methyl Tert-Butyl Ether", The New England Journal of Medicine, vol. 312, No. 4, Jan. 24, 1985, pp. 217-220.
Allen, M. J. et al., "Cholelitholysis Using Methyl Tertiary Butyl Ether", Gastroenterology, vol. 88 (1985), pp. 122-125.
Y. Takasawa et al., "A Study on the Dissolution and Disintegration of Calcium Bilirubinate Stones, with Special Reference to Effects of Litholytic Agents in Human Bile and to Irrigation of Bile Duct in Dogs", Tohoku J., Exp. Med., 1982, 138, 383-395.
U. Leuschner et al., "Alternating Treatment of Common Bile Duct Stones with a Modified Glyceryl-1-Monooctanoate Preparation and a Bile Acid-EDTA Solution by Masobiliary Tube", Scand. J. Gastroent., 1981, 16, 491-503.
U. Leuschner et al., "Gallstone Dissolution in the Biliary Tract: in Vitro Investigations on Inhabiting Factors and Special Dissolution Agents", American Journal of Gastroenterology, vol. 77, No. 4, 1982, 222-226.
U. Leuschner et al., "Biochemical and Morphological Investigations of the Toxicity of a Capmul Preparation and a Bile Salt-EDTA Solution in Patients with Bile Duct Stones", American Journal of Gastroenterology, vol. 77, No. 4, 1982, 222-226.
U. Leuschner et al., "Dissolution of Bileduct Stones", Letter to the Editor, The Lancet, Feb. 7, 1981, 336.
International Journal of Clinical Pharmacology, Therapy and Toxicology, vol. 21, No. 1, pp. 37-40 (1983).
International Journal of Clinical Pharmacology, Therapy and Toxicology, vol. 21, No. 2, pp. 95-97 (1985).
U. Leuschner et al., "The Dissolution of CBD Cholesterol and Pigment Stones with Methyl-Teritiary-Butyl-Ether (MTBE) in Vitro and in Vivo, Gastroenterology, vol. 88, No. 5, Parts 2, no year listed.
U. Leuschner et al., "Treatment of Bile Duct Stones by Combined Use of Endosceopy and Flushing Therapy", A/S/G/E, vol. 28, No. 2, 1982, p. 137.
U. Leuschner et al., "Dissolution of Black Pigment Stones (BPS) of the Gallbladder", Gastroentrerology, vol. 88, No. 5, Parts 2, no year listed.
U. Leuschner et al., "Our 10 Years' Experience in Gallstones Dissolution, (Comparison with the National Cooperative Gallstone Study (NCGS) and the Tokyo Cooperative Gallstone Study (TCGS), Japan)", no journal listed.
Hepatology, vol. 3, No. 5, p. 809 (1983).
International Journal of Clinical Pharmacology, Therapy and Toxicology, vol. 19, No. 6, pp. 273-274 (1981).
Br. F. Surg., vol. 68, pp. 203-308 (1981).
Comn, H. F.-Current Therapy l 1981-p. 366.
Allen Mark J.
Thistle Johnson L.
Bell Mark L.
Research Corporation
LandOfFree
Method for therapeutic use of methyl tertiary-butyl ether does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for therapeutic use of methyl tertiary-butyl ether, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for therapeutic use of methyl tertiary-butyl ether will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597731